AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+14.75%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.25B
AUM Growth
+$1.25B
(+16%)
Cap. Flow
-$23.1M
Cap. Flow
% of AUM
-1.85%
Top 10 Holdings %
Top 10 Hldgs %
36.71%
Holding
97
New
32
Increased
16
Reduced
15
Closed
25
Top Buys
| 1 |
Supernus Pharmaceuticals
SUPN
|
$40.6M |
| 2 |
Williams-Sonoma
WSM
|
$32.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
$32.1M |
| 4 |
Deckers Outdoor
DECK
|
$31.1M |
| 5 |
PTC Therapeutics
PTCT
|
$29.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$50.8M |
| 2 |
Energizer
ENR
|
$34.9M |
| 3 |
Assembly Biosciences
ASMB
|
$26.8M |
| 4 |
Foot Locker
FL
|
$26.5M |
| 5 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
$26.5M |
Sector Composition
| 1 | Healthcare | 58.42% |
| 2 | Consumer Discretionary | 23.75% |
| 3 | Consumer Staples | 8.12% |
| 4 | Technology | 3.92% |
| 5 | Industrials | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Restaurant Brands International
QSR
$20.5B
| $20M | 1.15% |
312,850
+132,850
| +74% | +$8.47M |
|
27
lululemon athletica
LULU
$23.8B
| $19.4M | 1.12% |
83,700
-51,300
| -38% | -$11.9M |
|
28
Catalyst Pharmaceutical
CPRX
$2.42B
| $19.1M | 1.1% |
+5,100,000
| New | +$19.1M |
|
29
Kiora Pharmaceuticals
KPRX
$9.61M
| $18M | 1.04% |
1,792,500
| – | – |
|
30
Ralph Lauren
RL
$19B
| $17.8M | 1.03% |
152,168
-79,832
| -34% | -$9.36M |
|
|
MRTX
31
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.5M | 0.89% |
+120,000
| New | +$15.5M |
|
|
TWNK
32
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $14.9M | 0.86% |
1,028,000
+448,000
| +77% | +$6.51M |
|
33
Qiagen
QGEN
$10.1B
| $14.9M | 0.86% |
+440,000
| New | +$14.9M |
|
34
Madrigal Pharmaceuticals
MDGL
$9.7B
| $14.6M | 0.84% |
160,000
+52,000
| +48% | +$4.74M |
|
35
O'Reilly Automotive
ORLY
$88.1B
| $14.5M | 0.83% |
33,000
-34,500
| -51% | -$15.1M |
|
36
Vertex Pharmaceuticals
VRTX
$102B
| $14.2M | 0.82% |
65,000
+35,000
| +117% | +$7.66M |
|
37
TJX Companies
TJX
$155B
| $12.9M | 0.74% |
+211,000
| New | +$12.9M |
|
38
Kohl's
KSS
$1.78B
| $12.7M | 0.73% |
+250,000
| New | +$12.7M |
|
39
Capri Holdings
CPRI
$2.51B
| $12.5M | 0.72% |
+326,611
| New | +$12.5M |
|
40
Five Below
FIVE
$8.33B
| $11.6M | 0.67% |
+90,457
| New | +$11.6M |
|
|
WBT
41
DELISTED
Welbilt, Inc.
WBT
| $11.3M | 0.65% |
724,000
-1,368,000
| -65% | -$21.4M |
|
42
United Therapeutics
UTHR
$17.7B
| $11.3M | 0.65% |
128,000
-102,000
| -44% | -$8.98M |
|
43
BJs Wholesale Club
BJ
$12.7B
| $10.8M | 0.62% |
+475,746
| New | +$10.8M |
|
|
MNK
44
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $9.35M | 0.54% |
+2,678,000
| New | +$9.35M |
|
|
PRTK
45
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $9.14M | 0.53% |
2,268,000
+696,000
| +44% | +$2.8M |
|
46
CRISPR Therapeutics
CRSP
$4.82B
| $9.01M | 0.52% |
148,000
-116,000
| -44% | -$7.07M |
|
47
TG Therapeutics
TGTX
$5.03B
| $8.88M | 0.51% |
+800,000
| New | +$8.88M |
|
|
VXRT
48
DELISTED
Vaxart
VXRT
| $8.83M | 0.51% |
25,200,000
+1,200,000
| +5% | +$421K |
|
|
ADMS
49
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $8.32M | 0.48% |
2,196,000
+1,660,000
| +310% | +$6.29M |
|
50
Tapestry
TPR
$21.7B
| $7.88M | 0.45% |
+292,046
| New | +$7.88M |
|